Sun Pharmaceutical Recalls Doxorubicin Hydrochloride Injection Due to Sterility Concerns
Sun Pharmaceutical Industries is recalling 393 vials of Doxorubicin Hydrochloride Liposome Injection due to a lack of assurance of sterility.
- Product
- DOXORUBICIN HYDROCHLORIDE — DOXORUBICIN HYDROCHLORIDE (DOXORUBICIN HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide